COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, published by TAYLOR & FRANCIS LTD, is a leading journal dedicated to the interdisciplinary field of biomechanics and biomedical engineering. With an ISSN of 1025-5842 and an E-ISSN of 1476-8259, this journal has been a significant resource since its inception in 1997 and will continue to publish cutting-edge research until 2024. The journal holds a respectable position in the academic community, categorized in Q3 of multiple domains including Bioengineering, Biomedical Engineering, and Human-Computer Interaction, reflecting its relevance across diverse fields. Although the journal does not offer open access, it provides valuable insights and methodologies essential for researchers, professionals, and students engaged in advancing computational techniques and their application in medicine and engineering. With Scopus rankings highlighting its growing influence, particularly in the Biomedical Engineering and Human-Computer Interaction sectors, this journal plays a crucial role in fostering innovation and enhancing the understanding of biomechanical systems through computational methods.

ANNALS OF BIOMEDICAL ENGINEERING is a premier journal in the field of biomedical engineering, published by Springer. Established in 1972, this journal has become a vital resource for researchers, professionals, and students engaged in the rapidly evolving domain of biomedical technology. With a commendable impact factor and ranked in the 76th percentile among its peers as per Scopus, it exemplifies excellence in disseminating critical research findings. The journal covers a broad scope of topics related to the integration of engineering principles with medical and biological sciences, facilitating innovations that enhance healthcare outcomes. Although open access is not offered in this journal, it remains an essential platform for scholarly communication, contributing to the continuous advancement of knowledge in biomedical engineering. ANNALS OF BIOMEDICAL ENGINEERING is not only a bridge for academics to share groundbreaking research but also an influential guide for practical applications in medicine and health technologies, making it a fundamental publication for its readership.

Biocybernetics and Biomedical Engineering, published by ELSEVIER in the Netherlands, is a prestigious journal that stands at the forefront of the intersecting fields of biomedical engineering and artificial intelligence. With an impressive Impact Factor that places it in the Q1 category for Biomedical Engineering, this journal not only ranks 17th out of 303 in Scopus but also boasts a remarkable percentile ranking of 94th, highlighting its influence and relevance within the scientific community. Since its inception in 2008, Biocybernetics and Biomedical Engineering has aimed to publish cutting-edge research that integrates principles of cybernetics with technological advancements in health care, thereby fostering innovations that improve patient outcomes. Dedicated to advancing knowledge in biomedical technology, the journal serves as a vital resource for researchers, professionals, and students seeking to explore the latest developments and methodologies in the field.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

Intelligent Medicine, published by Elsevier, is a leading open-access journal dedicated to advancing the fields of Artificial Intelligence, Biomedical Engineering, Health Informatics, and related areas within Medicine. Since its inception in 2021, it has quickly established itself among the top tier of academic publications, holding a commendable Q2 ranking in several categories, including a rank of #51 in Health Informatics and #104 in Medicine (Miscellaneous) as of 2023. The journal aims to disseminate innovative research that harnesses AI technologies to improve healthcare outcomes, bridging the gap between cutting-edge technology and medical practice. With its open-access model, Intelligent Medicine ensures broad dissemination of research findings, facilitating collaboration and knowledge sharing among researchers, practitioners, and students globally. Located in Amsterdam, Netherlands, this journal plays a pivotal role in shaping the future of intelligent healthcare solutions, inviting submissions that push the boundaries of conventional medicine through creative and impactful research.

IEEE Open Journal of Engineering in Medicine and Biology is a premier Open Access journal published by the esteemed IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC, dedicated to advancing the interdisciplinary fields of biomedical engineering and medicine. Since its inception in 2020, the journal has quickly established itself within the academic community, boasting a notable ranking of #49 out of 303 in the Biomedical Engineering category on Scopus and achieving an impressive 83rd percentile. With an objective of disseminating high-quality research and innovative developments that bridge engineering and medical sciences, the journal is committed to fostering collaboration among researchers, healthcare professionals, and policymakers. Operating with Open Access since 2020 allows for wider accessibility and dissemination of cutting-edge findings, promoting the exchange of knowledge vital for tackling contemporary challenges in health technology. As the journal continues to grow through to 2024, it remains a vital resource for anyone invested in the enhancement of medical technology and the betterment of patient care.

Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

Biomedical Engineering-Biomedizinische Technik, published by WALTER DE GRUYTER GMBH, serves as a pivotal platform for advancing knowledge in the field of biomedical engineering and medicine since its inception in 1956. With an ISSN of 0013-5585 and an E-ISSN of 1862-278X, this peer-reviewed journal offers accessible insights into innovative research and technological advancements that are reshaping healthcare practices and biomedical applications. Although rated in the Q3 category for both Biomedical Engineering and Miscellaneous Medicine in 2023, the journal's impact factor and growing reputation demonstrate its vital role in fostering academic dialogue and collaboration. The journal is based in Germany, while its scope encompasses a diverse range of topics, thus bridging the gap between engineering and medical disciplines. Researchers, professionals, and students alike are encouraged to engage with the content that not only highlights contemporary challenges but also presents groundbreaking solutions in biomedical technology.

The Journal of Mechanics in Medicine and Biology, published by World Scientific Publishing Co Pte Ltd, serves as a critical platform for interdisciplinary research at the intersection of engineering and biomedical sciences. With an ISSN of 0219-5194 and E-ISSN of 1793-6810, this esteemed journal has been dedicated to exploring the mechanical principles that govern biological systems since its inception in 2008. Based in Singapore, it addresses a diverse range of topics, from biomaterials to biomechanics, contributing valuable insights into the field’s evolving landscape. Although currently positioned in Q4 of Biomedical Engineering according to the 2023 category quartiles, it is poised for growth and increased visibility within the scientific community, fostering innovation and collaboration among researchers, professionals, and students alike. The journal emphasizes the importance of cutting-edge research and its practical implications, making it a vital resource for those striving to enhance the future of medical technologies and biological understanding.

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.